147 related articles for article (PubMed ID: 3489157)
21. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.
Galelli A; Anderson S; Charlot B; Alouf JE
J Immunol; 1989 Apr; 142(8):2855-63. PubMed ID: 2784816
[TBL] [Abstract][Full Text] [Related]
22. Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1.
Poindexter NJ; Schlievert PM
J Infect Dis; 1986 Apr; 153(4):772-9. PubMed ID: 3512737
[TBL] [Abstract][Full Text] [Related]
23. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.
Cullen CM; Blanco LR; Bonventre PF; Choi E
Infect Immun; 1995 Jun; 63(6):2141-6. PubMed ID: 7768593
[TBL] [Abstract][Full Text] [Related]
24. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.
Poindexter NJ; Schlievert PM
J Infect Dis; 1985 Jan; 151(1):65-72. PubMed ID: 3871225
[TBL] [Abstract][Full Text] [Related]
25. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
26. Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.
Stich N; Waclavicek M; Model N; Eibl MM
Toxins (Basel); 2010 Sep; 2(9):2272-88. PubMed ID: 22069685
[TBL] [Abstract][Full Text] [Related]
27. Bindings of toxic shock syndrome toxin-1 and staphylococcal enterotoxins A, B, and C to rabbit spleen cells.
Fujikawa H; Takayama H; Uchiyama T; Igarashi H
Microbiol Immunol; 1989; 33(5):381-90. PubMed ID: 2755362
[TBL] [Abstract][Full Text] [Related]
28. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation.
Mingari MC; Cambiaggi A; Vitale C; Schiavetti F; Bellomo R; Poggi A
Int Immunol; 1996 Feb; 8(2):203-9. PubMed ID: 8671605
[TBL] [Abstract][Full Text] [Related]
29. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Radons J; Burkart V; Kolb H
Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092
[TBL] [Abstract][Full Text] [Related]
30. Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1.
Edwin C; Swack JA; Williams K; Bonventre PF; Kass EH
J Infect Dis; 1991 Mar; 163(3):524-9. PubMed ID: 1995725
[TBL] [Abstract][Full Text] [Related]
31. Mitogenic properties of two distinct forms of toxic shock syndrome toxin-1 separated on hydroxyapatite by high-performance liquid chromatography.
Naidu AS; Eriksson KO; Hallberg T; Lindeberg J; Liao JL; Yao K; Wadström T; Hjertén S
APMIS; 1989 Dec; 97(12):1088-96. PubMed ID: 2558692
[TBL] [Abstract][Full Text] [Related]
32. Rapid histone deacetylation and transient HDAC association in the IL-2 promoter region of TSST-1-stimulated T cells.
Kametani Y; Wang L; Koduka K; Sato T; Katano I; Habu S
Immunol Lett; 2008 Aug; 119(1-2):97-102. PubMed ID: 18606456
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Hofer MF; Newell K; Duke RC; Schlievert PM; Freed JH; Leung DY
Proc Natl Acad Sci U S A; 1996 May; 93(11):5425-30. PubMed ID: 8643591
[TBL] [Abstract][Full Text] [Related]
35. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Cullen CM; Bonventre PF; Heeg H; Bluethmann H; Mountz JD; Edwards CK
Pathobiology; 1995; 63(6):293-304. PubMed ID: 8738468
[TBL] [Abstract][Full Text] [Related]
36. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
37. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
See RH; Kum WW; Chang AH; Goh SH; Chow AW
Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
[TBL] [Abstract][Full Text] [Related]
38. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.
Masuda K; Takei S; Nomura Y; Imanaka H; Sameshima K; Yoshinaga M
Pediatr Res; 1998 Jul; 44(1):27-31. PubMed ID: 9667366
[TBL] [Abstract][Full Text] [Related]
39. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
40. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
